Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT06546943
- Status
- Recruiting
Conditions
- Cystic Fibrosis Pulmonary Exacerbation
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 25 Years
- Healthy Volunteers
- Not accepted
Study Details
The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).
Key Dates
- Start date
- Feb 4, 2022
- Status verified
- Aug 2024
- Primary completion
- Apr 30, 2025
- Completion
- Oct 31, 2025
Study Design
- Enrollment
- 50 participants (estimated)
Primary Outcome Measure
CGM standard deviation [ Time Frame: 14 days ]
Central Contacts
- Christine Hovater720-777-6128
- Christine Chan, MD720-777-6128
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital Colorado, University of Colorado Denver | Aurora | Colorado | 80045 | Christine L Chan, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Aurora, CO
Related Studies
- Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside StudyPHASE4 · Recruiting · Chris Goss · Birmingham, Alabama